Neuraxis Q3 EPS $(1.35) Down From $(1.14) YoY, Sales $477.46K Down From $618.80K YoY
Portfolio Pulse from Benzinga Newsdesk
Neuraxis reported a decrease in Q3 earnings per share (EPS) from $(1.14) to $(1.35) year-over-year (YoY), and a 22.84% drop in sales from $618.80K to $477.46K YoY.
November 20, 2023 | 10:46 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Neuraxis reported a YoY decrease in Q3 EPS from $(1.14) to $(1.35) and a 22.84% drop in sales from $618.80K to $477.46K.
The reported decrease in both EPS and sales indicates a negative performance trend for Neuraxis, which is likely to be viewed unfavorably by investors. The significant drop in sales and increased losses are critical factors that can lead to a decline in the stock price in the short term. The confidence in this analysis is high due to the clear negative trend in fundamental financial metrics.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100